[JPM 2026] BMS’ ‘Selection Strategy’ seen from the case of Orum Therapeutic < JP Morgan Healthcare Conference 2026 < Industry < Text of article - Young Doctor This is from another article.
Just looking at these two articles, it is clear that BMS has incorporated Orum Therapeutic’s ORM-6151 (BMS-986497) as a core asset and will continue to do so.
You can see that it will grow. And traditionally, the stock price explodes about 3 months after JP Morgan Healthcare ends.
It was a time of rising enemies. This is my first time investing in bio, so I didn’t know this. I’m learning.
It gives you a chance. It’s up to each person to decide whether it’s flirting or an opportunity to flirt. Dry dishcloth in anticipation of 3 months
I’d like to try some guessing. Haha
p.s Last weekend, I went to a university gathering for the first time in a while and boasted about my stocks, and everyone told me to buy them because the prices were going up and down on Monday.
It fell even more yesterday haha I once again felt that people should be humble when it comes to stocks haha.
* This article is not a recommendation to buy or sell, but is only an individual’s subjective opinion *